We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies
CLGN

17 hedge funds and large institutions have $12.5M invested in CollPlant Biotechnologies in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more capital invested

Capital invested by funds: $10.9M → $12.5M (+$1.6M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.14% less ownership

Funds ownership: 13.84% → 13.69% (-0.14%)

6% less funds holding

Funds holding: 18 → 17 (-1)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Pinnacle Associates
New York
+$3.53M
2
SDJVC
St. Denis J. Villere & Co
Louisiana
+$21.3K
3
FIA
FNY Investment Advisers
New York
+$11.2K
4
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
+$371

Top Sellers

Rank Fund Capital Flow
1
BFEC
Benjamin F. Edwards & Company
Missouri
-$122K
2
SQA
Simon Quick Advisors
New Jersey
-$92.7K
3
SC
Shay Capital
New York
-$70.2K
4
UBS Group
UBS Group
Switzerland
-$10.6K
5
Morgan Stanley
Morgan Stanley
New York
-$364
Name Holding Trade Value Shares
Change 		Change in
Stake
RAM
1
Roumell Asset Management
Maryland
$4.69M – – –
PA
2
Pinnacle Associates
New York
$3.95M +$3.53M +484,653 New
SDJVC
3
St. Denis J. Villere & Co
Louisiana
$2.39M +$21.3K +2,926 +1%
Brown Advisory
4
Brown Advisory
Maryland
$603K – – –
BFEC
5
Benjamin F. Edwards & Company
Missouri
$399K -$122K -16,701 -25%
Zurich Cantonal Bank
6
Zurich Cantonal Bank
Switzerland
$188K +$371 +51 +0.2%
PA
7
Parallel Advisors
California
$78.5K – – –
Bank of America
8
Bank of America
North Carolina
$60.3K – – –
UBS Group
9
UBS Group
Switzerland
$53.4K -$10.6K -1,456 -18%
PNC Financial Services Group
10
PNC Financial Services Group
Pennsylvania
$29.4K – – –
FIA
11
FNY Investment Advisers
New York
$12K +$11.2K +1,539 New
GWM
12
Geneos Wealth Management
Colorado
$6.08K – – –
NA
13
NewEdge Advisors
Louisiana
$4.08K – – –
National Bank of Canada
14
National Bank of Canada
Quebec, Canada
$1.98K – – –
FWM
15
Focused Wealth Management
New York
$1.98K – – –
Morgan Stanley
16
Morgan Stanley
New York
$987 -$364 -50 -29%
First Manhattan
17
First Manhattan
New York
$816 – – –
SQA
18
Simon Quick Advisors
New Jersey
– -$92.7K -13,202 Closed
SC
19
Shay Capital
New York
– -$70.2K -10,000 Closed

CLGN Hedge Fund Activity: Q2 2023 in Review

17 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q2 2023, worth a combined $12.5M — up 15% from $10.9M a quarter earlier.

Fund positioning in CLGN was balanced in Q2 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was Pinnacle Associates, opening a new position worth an estimated $3.53M. The largest seller was Benjamin F. Edwards & Company, cutting an estimated $122K.

  • 17 institutional investors held CollPlant Biotechnologies (CLGN) as of Q2 2023, down from 18 in Q1 2023.
  • Funds reported $12.5M of CollPlant Biotechnologies stock for Q2 2023, up 15% quarter-over-quarter.
  • 2 funds opened new CollPlant Biotechnologies positions in Q2 2023 and 2 closed out, a net change of 0 holders.
  • The largest CollPlant Biotechnologies buyer in Q2 2023 was Pinnacle Associates, an estimated $3.53M added.
  • The largest CollPlant Biotechnologies seller in Q2 2023 was Benjamin F. Edwards & Company, an estimated $122K sold.

Based on aggregated 13F filings for Q2 2023.